Abstract
Living related donation is a well-established practice in pediatric liver transplantation, with more than 700 procedures having been performed world-wide so far (Anonymous 1997; Malago et al. 1997). Initially developed to alleviate the shortage of small grafts for children, living related liver transplantation (LRLT) is now a highly effective therapy for pediatric patients. It offers several advantages in comparison to transplantation of a cadaveric graft. Most importantly, living donation allows optimal timing of transplantation by reduction or even elimination of waiting time for a graft (BROELSCH et al. 1994). The elective timing allows transplantation to be performed in children before their medical condition deteriorates and thus reduces the risk of the transplant procedure. In addition, this entails a substantial psychological relief for both the patient and the family (Singer et al. 1990). Second, the graft quality of a living donated organ is in general excellent. The graft is procured from a healthy donor after careful medical screening under controlled, elective circumstances. Thus, a prolonged cold ischemic time can be avoided, reducing the risk of primary nonfunction of the graft (Broelsch et al. 1991; Emond et al. 1993). Third, immunological benefits involved with donation of an organ from a close blood relative are anticipated, although as yet this has not been clearly documented (Emond 1993).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, Kim JP (1997) The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease (see comments). N Engl J Med 336:747–754
Anonymous (1997) The International Living Donor Liver Transplantation Registry
Berenguer M, Terrault NA, Piatak M, et al. (1996) Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 111:1569–1575
Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL (1990) Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 212:368–375; discussion 375-377
Broelsch CE, Whitington PF, Emond JC, et al. (1991) Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg 214:428–437
Broelsch CE, Burdelski M, Rogiers X, et al (1994) Living donor for liver transplantation. Hepatology 20:49S–55S
Caplan A (1993) Must I be my brother’s keeper? Ethical issues in the use of living donors as sources of liver and other solid organs. Transplant Proc 25:1997–2000
Caplan AL (1994) Ethics of casting the first stone: personal responsibility, rationing, and transplants (editorial). Alcohol Clin Exp Res 18:219–221
D’Alessandro AM, Kalayoglu M, Sollinger HW, et al. (1991) The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 23:1536–1537
Dahlbaeck B (1995) New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 74:139–148
De Land F, North WA (1968) Relationship between liver size and body size. Radiology 91:1195–1198
Desmarais S, de Moerloose P, Reber G, Minazio P, Perrier A, Bounameaux H (1996) Resistance to activated protein C in an unselected population of patients with pulmonary embolism (see comments). Lancet 347:1374–1375
Devor M, Barrett-Connor E, Renvall M, Feigal D Jr, Ramsdell J (1992) Estrogen replacement therapy and the risk of venous thrombosis (see comments). Am J Med 92:275–282
Dickson RC, Qian KP, Lau JY (1997) High prevalence of GB virus-C/hepatitis G virus infection in liver transplant recipients. Transplantation 63:1695–1697
Emond JC (1993) Clinical application of liver-related liver transplantation. Gastroenterol Clin North Am 22:301–315
Emond JC, Heffron TG, Kortz EO, Gonzalez-Vallina R, Contis JC, Black DD, Whitington PF (1993) Improved results of living-related liver transplantation with routine application in a pediatric program. Transplantation 55:835–840
Feucht HH, Fischer L, Sterneck M, Knodler B, Broelsch CE, Laufs R (1997) GB virus C infection and liver transplantation: increased risk of transfusion-transmitted infection (letter). Blood 89:2223–2224
Fischer L, Malago M, Sterneck M, Broelsch C (1997) Controversies in living donor liver transplantation. Forum Trends Exp Clin Med 4:377–389
Goldhaber SZ, Savage DD, Garrison RJ, et al. (1983) Risk factors for pulmonary embolism. The Framingham Study. Am J Med 74:1023–1028
Goldhaber SZ, Grodstein F, Stampfer MJ, et al. (1997) A prospective study of risk factors for pulmonary embolism in women (see comments). JAMA 277:642–645
Griffin J, Evatt B (1981) deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370–1373
Hashimoto T, Manabe T, Shimizu Y, et al. (1996) ABO mismatched living related donor liver transplantation. Transplant Proc 28:1217–1219
Hoffmann R (1991) The thrombo-embolic risk in surgery. Hepatogastroenterology 38:272–278
Jones JW, Halldorsen L, Elick B, Granger DK, Matas AJ (1993) Unrecognized health problems diagnosed during living donor evaluation: a potential benefit. Transplant Proc 25:3083–3084
Kreis H (1993) Adverse events associated with OKT3 immu-nosuppression in the prevention or treatment of allograft rejection. Clin Transplant 74:31–46
Krupski G, Rogiers X, Nicolas V, et al (1996) Computed tomography versus magnetic resonance imaging-aided volumetry of the left lateral segment before living related liver donation: a case report. Liver Transplant Surg 2:388
Linnen J, Wages J Jr, Zhang Keck ZY, et al. (1996) Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505–508
Lo CM, Fan ST, Chan JK, Wei W, Lo RJ, Lai CL (1996) Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation 62:696–698
Malago M, Rogiers X, Broelsch CE (1997) Liver splitting and living donor techniques. Br Med Bull 53:860–867
Morimoto T, Tanaka A, Ikai I, et al. (1995) Donor safety in living related liver transplantation. Transplant Proc 27:1166–1169
Najarian JS, Chavers BM, McHugh LE, Matas AJ (1992) 20 years or more of follow-up of living kidney donors (see comments). Lancet 340:807–810
Pabinger I, Schneider B (1996) Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose-und Haemostaseforschung (GTH) Study Group on Natural Inhibitors. Arterioscler Thromb Vasc Biol 16:742–748
Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K (1994) The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 71:441–445
Renz JF, Mudge CL, Heyman MB, et al. (1995) Donor selection limits use of living-related liver transplantation. Hepatology 22:1122–1126
Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men (see comments). N Engl J Med 332:912–917
Schenkein DP, Schwartz RS (1997) Neoplasms and transplantation-trading swords for plowshares. N Engl J Med 336:949–950
Schwarz H, Fischer N, Hopmeier P, Bartard M, Griffin J (1984) Plasma protein S in familial thrombotic disease. Blood 64:1297–1300
Singer PA, Siegler M, Whitington PF, Lantos JD, Emond JC, Thistlethwaite JR, Broelsch CE (1989) Ethics of liver transplantation with living donors (see comments). N Engl J Med 321:620–622
Singer PA, Siegler M, Lantos JD, Emond JC, Whitington PF, Thistlethwaite JR, Broelsch CE (1990) The ethical assessment of innovative therapies: liver transplantation using living donors (see comments). Theor Med 11:87–94
Spital AL (1992) Unrelated living donors: should they be used? Transplant Proc 24:2215–2217
Spital AL, Spital M (1990) The ethics of liver transplantation from a living donor (letter; comment). N Engl J Med 322:549–550
Sterneck MR, Fischer L, Nischwitz U, et al. (1995) Selection of the living liver donor. Transplantation 60:667–671
Sterneck MR, Fischer L, Buggisch P, et al. (1996) Transplantation of complete and split liver grafts for patients with fulminant hepatic failure. Z Gastroenterol 34:795–800
Tanaka A, Tanaka K, Kitai T, et al. (1994a) Living related liver transplantation across ABO blood groups. Transplantation 58:548–553
Tanaka K, Uemoto S, Tokunaga Y, et al. (1994b) Living related liver transplantation in children. Am J Surg 168:41–48
Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol 1981:369–390
Todo S, Demetris AJ, Makowka L, et al. (1989) Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47:903–905
Ueda M, Uemoto S, Inomata Y, Okajima H, Hashida T, Tanaka K, Yamaoka Y (1995) A proposal of FK506 optimal dosing in living related liver transplantations. Transplantation 60:258–264
Whitington PF (1996) Living donor liver transplantation: ethical considerations. J Hepatol 24:625–627
Yamaoka Y, Washida M, Honda K, et al. (1994) Liver transplantation using a right lobe graft from a living related donor. Transplantation 57:1127–1130
Yamaoka Y, Morimoto T, Inamoto T, et al. (1995) Safety of the donor in living-related liver transplantation-an analysis of 100 parental donors. Transplantation 59:224–226
Yandza T, Lambert T, Alvarez F, et al. (1994) Outcome of ABO-incompatible liver transplantation in children with no specific alloantibodies at the time of transplantation. Transplantation 58:46–50
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sterneck, M. (2003). Evaluation of the Living Donor. In: Bücheler, E., Nicolas, V., Broelsch, C.E., Rogiers, X., Krupski, G. (eds) Diagnostic and Interventional Radiology in Liver Transplantation. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55955-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-55955-6_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62950-1
Online ISBN: 978-3-642-55955-6
eBook Packages: Springer Book Archive